Normal Hemostasis Values in Premature Infants
This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.
| Condition(s) | Premature Infant, Hemostasis |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants. |
| Who can participate | Inclusion Criteria: * Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter Exclusion Criteria: * Patients with incomplete data * Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency |
| Ages | 0 Months to 18 Months |
| Sex | All |
| Lead sponsor | University Hospital, Strasbourg, France |
| Locations | Strasbourg, France |
| Start date | 2025-11-24 |
| NCT ID | NCT07349251 |
| Official listing | https://clinicaltrials.gov/study/NCT07349251 |